United Kingdom · Question · Written question
UIN 40416
Prescription Drugs
Introduced
21 March 2025
Last action
27 March 2025 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
27 March 2025
Summary
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve access to SGLT2 inhibitors for patients with (a) type 2 diabetes, (b) chronic kidney disease and (c) heart failure.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
21 March 2025
Written question
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve access to SGLT2 inhibitors for patients with (a) type 2 diabetes, (b) chronic kidney disease and (c) heart failure.
Source: Commons
27 March 2025
Answer
The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing authoritative, evidence-based best practice guidance for the National Health Service.The NICE has been able to recommend two SGLT2 inhibitors, ...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2025-03-21/40416
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1787402
- uk · wq-1787402 · source updated 27 March 2025